SG11201805600VA - Deep sequencing profiling of tumors - Google Patents

Deep sequencing profiling of tumors

Info

Publication number
SG11201805600VA
SG11201805600VA SG11201805600VA SG11201805600VA SG11201805600VA SG 11201805600V A SG11201805600V A SG 11201805600VA SG 11201805600V A SG11201805600V A SG 11201805600VA SG 11201805600V A SG11201805600V A SG 11201805600VA SG 11201805600V A SG11201805600V A SG 11201805600VA
Authority
SG
Singapore
Prior art keywords
international
arizona
sequencing
applicants
pct
Prior art date
Application number
SG11201805600VA
Other languages
English (en)
Inventor
Nelson Alexander
Daniel Burgess
Stacey Stanislaw
Heidi Rosenbaum
Original Assignee
Ventana Med Syst Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventana Med Syst Inc, Hoffmann La Roche filed Critical Ventana Med Syst Inc
Publication of SG11201805600VA publication Critical patent/SG11201805600VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/146Concentration of target or template
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113PCR

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Prostheses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
SG11201805600VA 2016-01-15 2016-11-07 Deep sequencing profiling of tumors SG11201805600VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662279126P 2016-01-15 2016-01-15
US201662415952P 2016-11-01 2016-11-01
PCT/US2016/060835 WO2017123316A1 (en) 2016-01-15 2016-11-07 Deep sequencing profiling of tumors

Publications (1)

Publication Number Publication Date
SG11201805600VA true SG11201805600VA (en) 2018-07-30

Family

ID=57396824

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805600VA SG11201805600VA (en) 2016-01-15 2016-11-07 Deep sequencing profiling of tumors

Country Status (12)

Country Link
US (2) US11649492B2 (enrdf_load_stackoverflow)
EP (1) EP3402896B1 (enrdf_load_stackoverflow)
JP (2) JP7232643B2 (enrdf_load_stackoverflow)
KR (1) KR102398465B1 (enrdf_load_stackoverflow)
CN (1) CN108463559A (enrdf_load_stackoverflow)
AU (1) AU2016386032B2 (enrdf_load_stackoverflow)
CA (1) CA3011342C (enrdf_load_stackoverflow)
IL (1) IL260304B2 (enrdf_load_stackoverflow)
SA (1) SA518392005B1 (enrdf_load_stackoverflow)
SG (1) SG11201805600VA (enrdf_load_stackoverflow)
WO (1) WO2017123316A1 (enrdf_load_stackoverflow)
ZA (1) ZA201804322B (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3907299A1 (en) 2011-04-15 2021-11-10 The Johns Hopkins University Safe sequencing system
CN109457030B (zh) 2012-10-29 2022-02-18 约翰·霍普金斯大学 卵巢和子宫内膜癌的帕帕尼科拉乌测试
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
JP7232643B2 (ja) * 2016-01-15 2023-03-03 ヴェンタナ メディカル システムズ, インク. 腫瘍のディープシークエンシングプロファイリング
KR20250047324A (ko) 2017-08-07 2025-04-03 더 존스 홉킨스 유니버시티 암을 평가하고 치료하기 위한 방법 및 재료
US20200004928A1 (en) 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
CN109234356B (zh) * 2018-09-18 2021-10-08 南京迪康金诺生物技术有限公司 一种构建杂交捕获测序文库的方法及应用
EP3887547A1 (en) * 2018-11-29 2021-10-06 Ventana Medical Systems, Inc. Personalized ctdna disease monitoring via representative dna sequencing
WO2020136133A1 (en) 2018-12-23 2020-07-02 F. Hoffmann-La Roche Ag Tumor classification based on predicted tumor mutational burden
US20220310208A1 (en) 2019-06-13 2022-09-29 Roche Sequencing Solutions, Inc. Systems and methods with improved user interface for interpreting and visualizing longitudinal
WO2022244856A1 (ja) 2021-05-20 2022-11-24 Agc株式会社 ポリカーボネートの製造方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000159A (en) 1974-06-28 1976-12-28 Phillips Petroleum Company Preparation of n,n-disubstituted thioamides
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5176995A (en) 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
WO2009061840A1 (en) * 2007-11-05 2009-05-14 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation
EP2227563B1 (en) 2007-12-05 2012-06-06 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US8592150B2 (en) * 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
US20100029498A1 (en) * 2008-02-04 2010-02-04 Andreas Gnirke Selection of nucleic acids by solution hybridization to oligonucleotide baits
JP5757572B2 (ja) * 2009-07-03 2015-07-29 国立大学法人 東京大学 癌細胞の存否を判定する方法および癌患者の予後を判定する方法
JP5882234B2 (ja) 2010-02-25 2016-03-09 アドバンスト リキッド ロジック インコーポレイテッドAdvanced Liquid Logic, Inc. 核酸ライブラリーの作製方法
WO2012024658A2 (en) * 2010-08-20 2012-02-23 IntegenX, Inc. Integrated analysis system
KR20190100425A (ko) * 2010-12-30 2019-08-28 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화
GB2497510A (en) 2011-11-10 2013-06-19 Harry Cuppens Methods for determining mononucleotide sequence repeats
WO2014106076A2 (en) 2012-12-28 2014-07-03 Quest Diagnostics Investments Incorporated Universal sanger sequencing from next-gen sequencing amplicons
US20140278461A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center System and method for integrating a medical sequencing apparatus and laboratory system into a medical facility
WO2014144451A2 (en) * 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Biomarkers for response to rapamycin analogs
US10078724B2 (en) 2013-10-18 2018-09-18 Seven Bridges Genomics Inc. Methods and systems for genotyping genetic samples
US10415083B2 (en) * 2013-10-28 2019-09-17 The Translational Genomics Research Institute Long insert-based whole genome sequencing
JP7232643B2 (ja) * 2016-01-15 2023-03-03 ヴェンタナ メディカル システムズ, インク. 腫瘍のディープシークエンシングプロファイリング

Also Published As

Publication number Publication date
JP7232643B2 (ja) 2023-03-03
EP3402896A1 (en) 2018-11-21
IL260304B2 (en) 2025-04-01
JP7379418B2 (ja) 2023-11-14
AU2016386032A1 (en) 2018-07-12
IL260304A (en) 2018-08-30
ZA201804322B (en) 2022-10-26
KR20180098412A (ko) 2018-09-03
JP2021176302A (ja) 2021-11-11
BR112018014349A2 (pt) 2019-02-12
US20230250476A1 (en) 2023-08-10
IL260304B1 (en) 2024-12-01
SA518392005B1 (ar) 2022-02-08
US11649492B2 (en) 2023-05-16
CA3011342A1 (en) 2017-07-20
CA3011342C (en) 2023-03-14
US20180320229A1 (en) 2018-11-08
CN108463559A (zh) 2018-08-28
JP2019503182A (ja) 2019-02-07
WO2017123316A1 (en) 2017-07-20
EP3402896B1 (en) 2021-03-31
KR102398465B1 (ko) 2022-05-13
AU2016386032B2 (en) 2021-08-12

Similar Documents

Publication Publication Date Title
SG11201805600VA (en) Deep sequencing profiling of tumors
SG11201908847TA (en) Apparatuses, systems and methods for imaging flow cytometry
SG11201809051YA (en) Cell retention device and method
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201804506RA (en) Systems and methods for rendering multiple levels of detail
SG11201807068WA (en) Devices and methods for rapid pcr
SG11201808598UA (en) Detecting microbial infection in wounds
SG11201908288XA (en) Configurable annotations for privacy-sensitive user content
SG11201807269PA (en) Filamentous fungal biomats, methods of their production and methods of their use
SG11201901841TA (en) Targeting ligands
SG11201901860WA (en) Systems and methods for signaling missing or corrupted video data
SG11201805420SA (en) Antibodies and conjugates thereof
SG11201908240YA (en) Methods for evaluating tumor cell spheroids using 3d microfluidic cell culture device
SG11201807780XA (en) Customizable facility
SG11201408808WA (en) Method and system for treatment of biological tissue
SG11201407668XA (en) Method and device for detecting an analyte in a body fluid
SG11201908127WA (en) Method for producing multispecific antibodies
SG11201900057WA (en) Biomatrix scaffolds for use in diagnosing and modeling cancer
SG11201804841VA (en) Hardware integrity check
SG11201806400XA (en) Replicative transposon system
SG11201407891QA (en) Interest profile of a user of a mobile application
SG11201811467SA (en) A toxicant monitoring system
SG11201909501TA (en) Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro
SG11201407459QA (en) System and method for predicting the immunogenicity of a peptide
SG11201804415QA (en) Contrast agents